Marco Natali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marco Natali has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Agnarelli
Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square EC1M 6BQ , London
1 shared publication Anna Maria Bianucci
Istituto Nazionale per la Scienza e Tecnologia dei Materiali, Florence, Italy
1 shared publicationChiara Ippolito
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
1 shared publicationMaria Grazia Tozzi
Department of Biology, University of Pisa, Pisa, Italy
1 shared publicationMercedes Garcia-Gil
Department of Biology, University of Pisa, Pisa, Italy
1 shared publication- Nunzia Bernardini
University of Pisa
1 shared publication
Latest Publications
- Open Access
- 13 July 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-15
Cell-specific pattern of berberine pleiotropic effects on different human cell lines
The natural alkaloid berberine has several pharmacological properties and recently received attention as a potential anticancer agent. In this work, we investigated the molecular mechanisms underlying the anti-tumor effect of berberine on glioblastoma U343 and pancreatic carcinoma MIA PaCa-2 cells. Human dermal fibroblasts (HDF) were used as non-cancer cells. We show that berberine differentially affects cell viability, displaying a higher cytotoxicity on the two cancer cell lines than on HDF. Berberine also affects cell cycle progression, senescence, caspase-3 activity, autophagy and migration in a cell-specific manner. In particular, in HDF it induces cell cycle arrest in G2 and senescence, but not autophagy; in the U343 cells, berberine leads to cell cycle arrest in G2 and induces both senescence and autophagy; in MIA PaCa-2 cells, the alkaloid induces arrest in G1, senescence, autophagy, it increases caspase-3 activity and impairs migration/invasion. As demonstrated by decreased citrate synthase activity, the three cell lines show mitochondrial dysfunction following berberine exposure. Finally, we observed that berberine modulates the expression profile of genes involved in different pathways of tumorigenesis in a cell line-specific manner. These findings have valuable implications for understanding the complex functional interactions between berberine and specific cell types.
- 13 July 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-15
Open AccessCell-specific pattern of berberine pleiotropic effects on different human cell lines
The natural alkaloid berberine has several pharmacological properties and recently received attention as a potential anticancer agent. In this work, we investigated the molecular mechanisms underlying the anti-tumor effect of berberine on glioblastoma U343 and pancreatic carcinoma MIA PaCa-2 cells. Human dermal fibroblasts (HDF) were used as non-cancer cells. We show that berberine differentially affects cell viability, displaying a higher cytotoxicity on the two cancer cell lines than on HDF. Berberine also affects cell cycle progression, senescence, caspase-3 activity, autophagy and migration in a cell-specific manner. In particular, in HDF it induces cell cycle arrest in G2 and senescence, but not autophagy; in the U343 cells, berberine leads to cell cycle arrest in G2 and induces both senescence and autophagy; in MIA PaCa-2 cells, the alkaloid induces arrest in G1, senescence, autophagy, it increases caspase-3 activity and impairs migration/invasion. As demonstrated by decreased citrate synthase activity, the three cell lines show mitochondrial dysfunction following berberine exposure. Finally, we observed that berberine modulates the expression profile of genes involved in different pathways of tumorigenesis in a cell line-specific manner. These findings have valuable implications for understanding the complex functional interactions between berberine and specific cell types.